Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious OutperformanceFind Stocks Now

In Roundup case, U.S. judge cuts $2 billion verdict against Bayer to $86 million

Published 26/07/2019, 02:23
Updated 26/07/2019, 02:26
In Roundup case, U.S. judge cuts $2 billion verdict against Bayer to $86 million

By Tina Bellon

(Reuters) - A California judge on Thursday reduced a $2 billion (£1.6 billion) jury verdict, slashing the award for a couple who blamed Bayer AG's (DE:BAYGn) glyphosate-based weed killer Roundup for their cancer to $86.7 million (£69.6 million).

Superior Court Judge Winifred Smith of the California Superior Court in Oakland said the jury's billion-dollar punitive damages awards were excessive and unconstitutional, but rejected Bayer's request to strike the punitive award outright.

Under Smith's final order, California couple Alva and Alberta Pilliod would receive roughly $17 million in compensatory and $69 million in punitive damages, down from $55 million and $2 billion, respectively.

The plaintiffs still have to formally accept the reduced award.

Bayer in a statement on Thursday said Smith's decision to slash the award was a step in the right direction, but added it would file an appeal.

"We continue to believe that the verdict and damage awards are not supported by the evidence at trial and conflict with the extensive body of reliable science and conclusions of leading health regulators worldwide that confirms glyphosate-based herbicides can be used safely and that glyphosate is not carcinogenic," the company said.

Bayer faces Roundup cancer lawsuits by more than 13,400 plaintiffs across the United States. The Germany-based company bought Roundup maker Monsanto (NYSE:MON) in a $63 billion deal last year, but has since seen its share price tumble over the glyphosate litigation.

Plaintiffs allege Roundup causes non-Hodgkin's lymphoma and that Monsanto for decades tried to influence scientists and regulators to bury cancer evidence. Bayer denies those allegations.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

The company had asked Smith to strike the punitive damages award in the Pilliods' case, arguing that hundreds of studies and assessments by regulators worldwide concluded the herbicide to be safe for human use.

But the judge in her Thursday order rejected those arguments.

"In this case there was clear and convincing evidence that Monsanto made efforts to impede, discourage, or distort scientific inquiry and the resulting science," Smith said.

Bayer to date has lost three U.S. jury trials in the Roundup litigation, with juries in California awarding multi-million dollar awards. It is appealing the decisions.

In August, the company is scheduled to face its first trial outside California at a courthouse in St. Louis, Missouri. Monsanto has recruited Missouri-based expert witnesses to make its case in a place where it has century-old roots but where juries often hit companies with huge damages.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.